Adherence to dornase alfa treatment among commercially insured patients with cystic fibrosis
Authors:
- 4 April 2013
- journal article
- Published by Informa Healthcare in Journal of Medical Economics
- Vol. 16 (6) , 801-808
Abstract
(2013). Adherence to dornase alfa treatment among commercially insured patients with cystic fibrosis. Journal of Medical Economics: Vol. 16, No. 6, pp. 801-808. doi: 10.3111/13696998.2013.787427Keywords
This publication has 15 references indexed in Scilit:
- Longitudinal association between medication adherence and lung health in people with cystic fibrosisJournal of Cystic Fibrosis, 2011
- Updating and Validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge Abstracts Using Data From 6 CountriesAmerican Journal of Epidemiology, 2011
- Healthcare expenditures for privately insured people with cystic fibrosisPediatric Pulmonology, 2009
- Medication Compliance and Persistence: Terminology and DefinitionsValue in Health, 2008
- Cystic Fibrosis Pulmonary GuidelinesAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Potentially Avoidable Hospitalizations for COPD and PneumoniaMedical Care, 2007
- A Checklist for Medication Compliance and Persistence Studies Using Retrospective DatabasesValue in Health, 2007
- Out-Of-Pocket Medical Spending For Care Of Chronic ConditionsHealth Affairs, 2001
- Adapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJournal of Clinical Epidemiology, 1992
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987